“Global Anti-Aging Services and Surgical market is anticipated to reach $40.76bn by 2029”, says Visiongain report

04 September 2019
Pharma

Visiongain has launched a new pharma report Anti-aging Services & Surgical Market Report 2019-2029: By Product (Anti-stretch Mark Products, Anti-Wrinkle Products, Botox, Dermal Fillers, Hair Color, UV Absorbers), Services (Anti Pigmentation Therapy, Adult Acne Therapy, Breast Augmentation, Liposuction Services, Abdominoplasty, Chemical Peel, Eye-Lid Surgery, Hair Restoration Services, Sclerotherapy), Device (Anti-Cellulite Treatment, Micoderm Abrasion, Laser Aesthetic, Radiofrequency) and Geography

Global Anti-aging services and surgical market is anticipated to grow on account of rapidly ageing, increasing beauty and health awareness among generation X and Y, and affluent baby boomer population. The global Anti-aging services and surgical market is anticipated to grow at a lucrative CAGR of 5.6% and anticipated to reach USD 40.76 Million by 2029.

Significant increase in worldwide demand for anti-aging products, services and processes is directly linked to the increasing incidence of women's skin cancer. The American Plastic Surgeons Society observed that each of five American females is at danger of developing skin cancer, increasing rapidly over the past three decades. Most skin cancers grow on the body, such as basal cell carcinoma and squamous cell carcinoma, and can be quite disfiguring. This fuel the demand for appropriate reconstructive anti-aging processes. Nose is the main region impacted in the anti-aging industry, followed by cheeks, ears and forehead.

North America holds majority of market share followed by Europe and will continue to dominate in the future as a result of surging incidences of sedentary lifestyle, rising concerns regarding signs of aging, and technological advancements among other prominent factors to boost the growth of the market in this region.  Asia Pacific region is expected to experience the highest growth in terms of CAGR over the forecast period owing to growing awareness in developing regions such as Japan, China and India.

Ageing is a worldwide problem, especially in South Korea, Japan, and China –nations most impacted by a fast-growing population. It makes sense, therefore, that these North Asian markets are at the forefront of Asia Pacific's anti-aging beauty. The increasing silver generation of the region is opening up possibilities for anti-aging surgery to capitalize on the' gray wave.'

Currently, key players are forming various strategies such as acquisitions, mergers, partnerships, collaborations and launching new products in order to strengthen their position in the global anti-aging services and surgical market. Companies are also expanding their R&D, distribution, and management facilities in order to expand their business and to hold a competitive edge in the market. For instance, Ellipse A / S was acquired by Syneron Medical Ltd. in September 2018 which would help company to strengthen its position and provide a comprehensive portfolio for skin aesthetic treatments.

The comprehensive market report features companies such as Alma Laser, Beiersdorf AG,  Cynosure, Inc., L'Oréal SA, Lumenis Ltd, Nu Skin Enterprises, Peptron, Personal Microderm (PMD), Photomedex, Solta Medical Inc. (Valeant Pharmaceuticals), and SomaDex among other prominent players.

Also the research study offers market estimation and forecast for the period ranging 2019–2029 for global markets such as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific and MEA along with regional sub-markets as U.S., Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Nordic, Benelux, Russia, Poland, India, Japan, China, Australia, ASEAN, GCC, South Africa and North Africa.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

 

Recent News

“Oncology remains the largest disease area in the pharmaceutical business. The oncology market is dominated by big pharma companies and high price labels” says Visiongain report

Although price is still the most important competitive advantage for a biosimilar company, current discount rates are not enough to automatically convince the key stakeholders of a biosimilar’s value.

10 September 2019

Read

“Anti-Infective Agents market set to grow to $141bn by 2024” says new Visiongain report

The global anti-infective agents market is one that is driven by innovation. This is vital for maintaining the rich pipeline of anti-infective agents seen in the market today.

09 September 2019

Read

“Global thyroid gland disorder treatment market is anticipated to grow at a lucrative CAGR of 3.6% and anticipated to reach USD 3.21 Billion by 2029”, says Visiongain report.

Thyroid disease is one of today’s most prevalent hormonal illnesses. Hyperthyroidism, hypothyroidism, and thyroid nodules are the most common thyroid gland disorders.

05 September 2019

Read

“Global somatostatin analogs market is anticipated to grow at a lucrative CAGR of 5.3% and anticipated to reach USD 4.78 Bn by 2029”, says Visiongain report.

Somatostatin was used to diagnose gastrointestinal tract tumors and acromegaly in the clinical environment.

05 September 2019

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever